http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012022020-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_091948196f6e8cd318cea821e4222779 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_939c0a2954cb655d793b68b1dc6724fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa6c0d1288cd918a9e88ed59485484f9 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2011-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fca706e261d9f9165e69d7b9c1b03e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_403976822ff3071b0b82cb5f73cc1ba3 |
| publicationDate | 2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2012022020-A1 |
| titleOfInvention | Pharmaceutical forms for the release of active compounds |
| abstract | A pharmaceutical composition containing a sulfated glycosaminoglycan drug and a polycationic polymer or copolymer wherein the proportion of ammonium groups in the pharmaceutical composition is between 0.01-2.0 μmol ammonium groups/mg pharmaceutical composition, the proportion of glycosaminoglycan in the pharmaceutical form is between 15% to 50% w/w, and the pharmaceutical composition possesses a moisture content of 10% wt or less. A pharmaceutical dosage form containing the pharmaceutical composition, and their use for the treatment of diseases or disorders therapeutically responsive to the glycosaminoglycan. |
| priorityDate | 2007-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 301.